The citations below is a result of Institute
for Scientific Information Science
Citation Index search
Citing Article
THE
CEREBROSPINAL-FLUID SOLUBLE FORM OF ALZHEIMERS AMYLOID-BETA IS COMPLEXED
TO SP-40,40 (APOLIPOPROTEIN-J), AN INHIBITOR OF THE COMPLEMENT MEMBRANE-ATTACK
COMPLEX
GHISO J, MATSUBARA E, KOUDINOV A, et al.
BIOCHEMICAL JOURNAL
293: 27-30, Part 1 JUL 1 1993
121
papers by February 1, 2001
111-121
Chodobski A, Szmydynger-Chodobska
J
Choroid plexus: Target for polypeptides and site of their synthesis
MICROSC RES TECHNIQ 52: (1) 65-82 JAN 1 2001
Candiano G, Musante L, Carraro
M, et al.
Apolipoproteins prevent glomerular albumin permeability induced in vitro
by serum from patients with focal segmental glomerulosclerosis
J AM SOC NEPHROL 12: (1) 143-150 JAN 2001
Munson GW, Roher AE, Kuo YM,
et al.
SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid
peptides
BIOCHEMISTRY-US 39: (51) 16119-16124 DEC 26 2000
Shibata M, Yamada S, Kumar SR,
et al.
Clearance of Alzheimer's amyloid-beta(1-40) peptide from brain by LDL receptor-related
protein-1 at the blood-brain barrier
J CLIN INVEST 106: (12) 1489-1499 DEC 2000
LaDu MJ, Shah JA, Reardon CA,
et al.
Apolipoprotein E receptors mediate the effects of
beta-amyloid on astrocyte cultures
J BIOL CHEM 275: (43) 33974-33980 OCT 27 2000
Xu Q, Li YH, Cyras C, et al.
Isolation and characterization of apolipoproteins
from murine microglia - Identification of a low density lipoprotein-like
apolipoprotein J-rich but E-poor spherical particle
J BIOL CHEM 275: (41) 31770-31777 OCT 13 2000
Mulder C, Scheltens P, Visser
JJ, et al.
Genetic and biochemical markers for Alzheimer's
disease: recent developments
ANN CLIN BIOCHEM 37: 593-607 Part 5 SEP 2000
Fagan AM, Holtzman DM
Astrocyte lipoproteins, effects of apoE on neuronal
function, and role of apoE in amyloid-beta deposition in vivo
MICROSC RES TECHNIQ 50: (4) 297-304 AUG 15 2000
Calero M, Rostagno A, Matsubara
E, et al.
Apolipoprotein J (clusterin) and Alzheimer's disease
MICROSC RES TECHNIQ 50: (4) 305-315 AUG 15 2000
Cole GM, Ard MD
Influence of lipoproteins on microglial degradation
of Alzheimer's amyloid beta-protein
MICROSC RES TECHNIQ 50: (4) 316-324 AUG 15 2000
Roher AE, Baudry J, Chaney
MO, et al.
Oligomerization and fibril assembly of the amyloid-beta
protein
BBA-MOL BASIS DIS 1502: (1) 31-43 JUL 26 2000
101-110
LaDu MJ, Reardon C, Van Eldik
L, et al.
Lipoproteins in the central nervous system
ANN NY ACAD SCI 903: 167-175 2000
Tsuzuki K, Fukatsu R, Yamaguchi
H, et al.
Transthyretin binds amyloid beta peptides, A beta
1-42 and A beta 1-40 to form complex in the autopsied human
kidney - possible role of transthyretin for A beta
sequestration
NEUROSCI LETT 281: (2-3) 171-174 MAR 10 2000
Wilson MR, Easterbrook-Smith
SB
Clusterin is a secreted mammalian chaperone
TRENDS BIOCHEM SCI 25: (3) 95-98 MAR 2000
Stoltzner SE, Grenfell TJ, Mori
C, et al.
Temporal accrual
of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's
disease
AM J PATHOL 156: (2) 489-499 FEB 2000
Ray I, Chauhan A, Wegiel J, et
al.
Gelsolin inhibits
the fibrillization of amyloid beta-protein, and also defibrillizes its
preformed fibrils
BRAIN RES 853: (2) 344-351 JAN 24 2000
Pappolla MA, Chyan YJ, Poeggeler
B, et al.
An assessment
of the antioxidant and the antiamyloidogenic properties of melatonin: implications
for Alzheimer's disease
J NEURAL TRANSM 107: (2) 203-231 2000
Koudinov AR, Koudinova NV, Berezov
TT, et al.
HDL phospholipid:
a natural inhibitor of Alzheimer's amyloid beta-fibrillogenesis?
CLIN CHEM LAB MED 37: (10) 993-994 OCT 1999
Maioli E, Torricelli C, Santucci
A, et al.
Molecular
assembly of endogenous and synthetic big atrial natriuretic peptide (ANP)
and its amyloidogenic implications
BBA-MOL BASIS DIS 1500: (1) 31-40 JAN 3 2000
-
Fagan AM, Holtzman DM, Munson
G, et al.
-
Unique
lipoproteins secreted by primary astrocytes from wild type, apoE (-/-),
and human apoE transgenic mice
J BIOL CHEM 274: (42) 30001-30007 OCT 15 1999
-
Nishida I, Quantock AJ, Dota
A, et al.
-
Apolipoproteins
J and E co-localise with amyloid in gelatinous drop-like and lattice type
I corneal dystrophies
BRIT J OPHTHALMOL 83: (10) 1178-1182 OCT 1999
-
91-100
-
Cole GM, Beech W, Frautschy SA,
et al.
-
Lipoprotein
effects on A beta accumulation and degradation by microglia in vitro
J NEUROSCI RES 57: (4) 504-520 AUG 15 1999
-
Koudinova NV, Berezov TT, Koudinov
AR
-
beta-amyloid:
Alzheimer's disease and brain beta-amyloidoses
BIOCHEMISTRY-MOSCOW+ 64: (7) 752-757 JUL 1999
-
Hochgrebe TT, Humphreys D, Wilson
MR, et al.
-
A reexamination
of the role of clusterin as a complement regulator
EXP CELL RES 249: (1) 13-21 MAY 25 1999
-
Chauhan VPS, Ray I, Chauhan A,
et al.
-
Binding
of gelsolin, a secretory protein, to amyloid beta-protein
BIOCHEM BIOPH RES CO 258: (2) 241-246 MAY 10 1999
-
Figueiredo-Pereira ME, Efthimiopoulos
S, Tezapsidis N, et al.
-
Distinct
secretases, a cysteine protease and a serine protease, generate the C termini
of amyloid beta-proteins A beta(1-40) and A beta(1-42), respectively
J NEUROCHEM 72: (4) 1417-1422 APR 1999
-
Verbeek MM, Otte-Holler I, Ruiter
DJ, et al.
-
Human
brain pericytes as a model system to study the pathogenesis of cerebrovascular
amyloidosis in Alzheimer's disease
CELL MOL BIOL 45: (1) 37-46 FEB 1999
-
Mahon MG, Lindstedt KA, Hermann
M, et al.
-
Multiple
involvement of clusterin in chicken ovarian follicle development - Binding
to two oocyte-specific members of the low density lipoprotein receptor
gene family
J BIOL CHEM 274: (7) 4036-4044 FEB 12 1999
Lidstrom AM, Bogdanovic N, Hesse
C, et al.
Clusterin
(apolipoprotein J) protein levels are increased in hippocampus and in frontal
cortex in Alzheimer's disease
EXP NEUROL 154: (2) 511-521 DEC 1998
Janciauskiene S, Wright HT
Inflammation,
antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's
disease
BIOESSAYS 20: (12) 1039-1046 DEC 1998
Eikelenboom P, Rozemuller JM,
van Muiswinkel FL
Inflammation
and Alzheimer's disease: Relationships between pathogenic mechanisms and
clinical expression
EXP NEUROL 154: (1) 89-98 NOV 1998
81-90
Frautschy SA, Horn DL, Sigel
JJ, et al.
Protease
inhibitor coinfusion with amyloid beta-protein results in enhanced deposition
and toxicity in rat brain
J NEUROSCI 18: (20) 8311-8321 OCT 15 1998
Ray I, Chauhan A, Wisniewski
HM, et al.
Binding
of amyloid beta-protein to intracellular brain proteins in rat and human
NEUROCHEM RES 23: (10) 1277-1282 OCT 1998
Koudinov AR, Berezov TT, Koudinova
NV
Alzheimer's
amyloid beta and lipid metabolism: a missing link?
FASEB J 12: (12) 1097-1099 SEP 1998
Teplow DB
Structural
and kinetic features of amyloid beta-protein fibrillogenesis
AMYLOID 5: (2) 121-142 JUN 1998
Lambert MP, Barlow AK, Chromy
BA, et al.
Diffusible,
nonfibrillar ligands derived from A beta(1-42) are potent central nervous
system neurotoxins
P NATL ACAD SCI USA 95: (11) 6448-6453 MAY 26 1998
Pankhurst GJ, Bennett CA, Easterbrook-Smith
SB
Characterization
of the heparin-binding properties of human clusterin
BIOCHEMISTRY-US 37: (14) 4823-4830 APR 7 1998
Blain H, Jeandel C
Alzheimer's
disease - Markers in the cerebrospinal fluid in support of the pathogenic
hypotheses
PRESSE MED 27: (15) 731-738 APR 18 1998
Wisniewski T, Ghiso J, Frangione
B
Biology
of A beta amyloid in Alzheimer's disease
NEUROBIOL DIS 4: (5) 313-328 1997
Zubenko GS
Molecular
neurobiology of Alzheimer's disease (syndrome?)
HARVARD REV PSYCHIAT 5: (4) 177-213 NOV-DEC 1997
Humphreys D, Hochgrebe TT, EasterbrookSmith
SB, et al.
Effects
of clusterin overexpression on TNF alpha- and TGF beta-mediated death of
L929 cells
BIOCHEMISTRY-US 36: (49) 15233-15243 DEC 9 1997
71-80
Permanne B, Perez C, Soto C,
et al.
Detection
of apolipoprotein E dimeric soluble amyloid beta complexes in Alzheimer's
disease brain supernatants
BIOCHEM BIOPH RES CO 240: (3) 715-720 NOV 26 1997
Martel CL, Mackic JB, Matsubara
E, et al.
Isoform-specific
effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration
and blood-brain barrier transport of circulating Alzheimer's amyloid beta
J NEUROCHEM 69: (5) 1995-2004 NOV 1997
Verbeek MM, Ruiter DJ, deWaal
RMW
The role
of amyloid in the pathogenesis of Alzheimer's disease
BIOL CHEM 378: (9) 937-950 SEP 1997
Sberna G, SaezValero J, Beyreuther
K, et al.
The amyloid
beta-protein of Alzheimer's disease increases acetylcholinesterase expression
by increasing intracellular calcium in embryonal carcinoma P19 cells
J NEUROCHEM 69: (3) 1177-1184 SEP 1997
Brown AM, Tummolo DM, Rhodes
KJ, et al.
Selective
aggregation of endogenous beta-amyloid peptide and soluble amyloid precursor
protein in cerebrospinal fluid by zinc
J NEUROCHEM 69: (3) 1204-1212 SEP 1997
Aleshkov S, Abraham CR, Zannis
VI
Interaction
of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells
with amyloid peptide beta (1-40). Relevance to Alzheimer's disease
BIOCHEMISTRY-US 36: (34) 10571-10580 AUG 26 1997
Mitsuhashi T, Li YM, Fishbane
S, et al.
Depletion
of reactive advanced glycation endproducts from diabetic uremic sera using
a lysozyme-linked matrix
J CLIN INVEST 100: (4) 847-854 AUG 15 1997
Hammad SM, Ranganathan S, Loukinova
E, et al.
Interaction
of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein
receptor-related protein-2 megalin - A mechanism to prevent pathological
accumulation of amyloid beta-peptide
J BIOL CHEM 272: (30) 18644-18649 JUL 25 1997
Haas C, Cazorla P, DeMiguel C,
et al.
Apolipoprotein
E forms stable complexes with recombinant Alzheimer's disease beta-amyloid
precursor protein
BIOCHEM J 325: 169-175 Part 1 JUL 1 1997
Verbeek MM, Eikelenboom P, deWaal
RMW
Differences
between the pathogenesis of senile plaques and congophilic angiopathy in
Alzheimer disease
J NEUROPATH EXP NEUR 56: (7) 751-761 JUL 1997
61-70
Koudinov AR, Koudinova NV
Alzheimer's
soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein
CELL BIOL INT 21: (5) 265-271 MAY 1997
McDonald JF, Nelsestuen GL
Potent
inhibition of terminal complement assembly by clusterin: Characterization
of its impact on C9 polymerization
BIOCHEMISTRY-US 36: (24) 7464-7473 JUN 17 1997
Ogawa S, Ishibashi Y, Sakamoto
Y, et al.
The glycoproteins
that occur in the colloids of senescent porcine pituitary glands are clusterin
and glycosylated albumin fragments
BIOCHEM BIOPH RES CO 234: (3) 712-718 MAY 29 1997
Martel CL, Ghiso J, Frangione
B, et al.
Transport
of apolipoproteins E and J at the blood-brain barrier - Relevance to Alzheimer's
disease
STP PHARMA SCI 7: (1) 28-36 JAN-FEB 1997
Dickson DW
The pathogenesis
of senile plaques
J NEUROPATH EXP NEUR 56: (4) 321-339 APR 1997
Koudinova NV, Koudinov AR, Berezov
TT
The amyloid
beta protein in normal human plasma and cerebrospinal fluid is associated
with high density lipoproteins.
VOP MED KHIM 42: (3) 253-262 JUL-SEP 1996
JohnsonWood K, Lee M, Motter
R, et al.
Amyloid
precursor protein processing and A beta(42) deposition in a transgenic
mouse model of Alzheimer disease
P NATL ACAD SCI USA 94: (4) 1550-1555 FEB 18 1997
MessmerJoudrier S, Sagot Y, Mattenberger
L, et al.
Injury-induced
synthesis and release of apolipoprotein E and clusterin from rat neural
cells
EUR J NEUROSCI 8: (12) 2652-2661 DEC 1996
Shayo M, McLay RN, Kastin AJ,
et al.
The putative
blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein
J is saturated at physiological concentrations
LIFE SCI 60: (7) PL115-PL118 JAN 10 1997
Biere AL, Ostaszewski B, Stimson
ER, et al.
Amyloid
beta-peptide is transported on lipoproteins and albumin in human plasma
J BIOL CHEM 271: (51) 32916-32922 DEC 20 1996
51-60
Saitoh T, Kang D, Mallory M,
et al.
Glial
cells in Alzheimer's disease: Preferential effect of APOE risk on scattered
microglia
GERONTOLOGY 43: (1-2) 109-118 JAN-APR 1997
Roeth PJ, EasterbrookSmith SB
C1q is
a nucleotide binding protein and is responsible for the ability of clusterin
preparations to promote immune complex formation
BBA-PROTEIN STRUCT M 1297: (2) 159-166 OCT 17 1996
Frangione B, Castano EM, Wisniewski
T, et al.
Apolipoprotein
E and amyloidogenesis
CIBA F SYMP 199: 132-145 1996
Schwarzman AL, Goldgaber D, Palha,
et al.
Interaction
of transthyretin with amyloid beta-protein: Binding and inhibition of amyloid
formation
CIBA F SYMP 199: 146-164 1996
Webster S, Rogers J
Relative
efficacies of amyloid beta peptide (A beta) binding proteins in A beta
aggregation
J NEUROSCI RES 46: (1) 58-66 OCT 1 1996
Eikelenboom P, Veerhuis R
The role
of complement and activated microglia in the pathogenesis of Alzheimer's
disease
NEUROBIOL AGING 17: (5) 673-680 SEP-OCT 1996
ChoiMiura NH, Oda T
Relationship
between multifunctional protein ''clusterin'' and Alzheimer disease
NEUROBIOL AGING 17: (5) 717-722 SEP-OCT 1996
Zlokovic BV
Cerebrovascular
transport of Alzheimer's amyloid beta and apolipoproteins J and E: Possible
anti-amyloidogenic role of the blood-brain barrier
LIFE SCI 59: (18) 1483-1497 SEP 27 1996
Ida N, Hartmann T, Pantel J,
et al.
Analysis
of heterogeneous beta A4 peptides in human cerebrospinal fluid and blood
by a newly developed sensitive Western blot assay
J BIOL CHEM 271: (37) 22908-22914 SEP 13 1996
Chauhan A, Pirttila T, Mehta
P, et al.
Effect
of cerebrospinal fluid from normal and Alzheimer's patients with different
apolipoprotein E phenotypes on in vitro aggregation of amyloid beta-protein
J NEUROL SCI 141: (1-2) 54-58 SEP 15 1996
41-50
Yan SD, Chen X, Fu J, et al.
RAGE
and amyloid-beta peptide neurotoxicity in Alzheimer's disease
NATURE 382: (6593) 685-691 AUG 22 1996
Boggs LN, Fuson KS, Baez M, et
al.
Clusterin
(Ape J) protects against in vitro amyloid-beta(1-40) neurotoxicity
J NEUROCHEM 67: (3) 1324-1327 SEP 1996
Tycko B, Feng L, Nguyen L, et
al.
Polymorphisms
in the human apolipoprotein-J/clusterin gene: Ethnic variation and distribution
in Alzheimer's disease
HUM GENET 98: (4) 430-436 OCT 1996
GhersiEgea JF, Gorevic PD, Ghiso
J, et al.
Fate
of cerebrospinal fluid-borne amyloid beta-peptide: Rapid clearance into
blood and appreciable accumulation by cerebral arteries
J NEUROCHEM 67: (2) 880-883 AUG 1996
Koudinov AR, Koudinova NV, Kumar
A, et al.
Biochemical
characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal
fluid: Association with high density lipoproteins
BIOCHEM BIOPH RES CO 223: (3) 592-597 JUN 25 1996
Zlokovic BV, Martel CL, Matsubara
E, et al.
Glycoprotein
330/megalin: Probable role in receptor-mediated transport of apolipoprotein
J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain
and blood-cerebrospinal fluid barriers
P NATL ACAD SCI USA 93: (9) 4229-4234 APR 30 1996
Inestrosa NC, Alvarez A, Perez
CA, et al.
Acetylcholinesterase
accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils:
Possible role of the peripheral site of the enzyme
NEURON 16: (4) 881-891 APR 1996
Golabek AA, Soto C, Vogel T,
et al.
The interaction
between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent
on beta-peptide conformation
J BIOL CHEM 271: (18) 10602-10606 MAY 3 1996
Strittmatter WJ, Roses AD
Apolipoprotein
E and Alzheimer's disease
ANNU REV NEUROSCI 19: 53-77 1996
Palha JA, Moreira P, Wisniewski
T, et al.
Transthyretin
gene in Alzheimer's disease patients
NEUROSCI LETT 204: (3) 212-214 FEB 9 1996
31-40
MAZURKOLECKA B, FRACKOWIAK J,
WISNIEWSKI HM
APOLIPOPROTEINS
E3 AND E4 INDUCE, AND TRANSTHYRETIN PREVENTS ACCUMULATION OF THE ALZHEIMERS
BETA-AMYLOID PEPTIDE IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS
BRAIN RES 698: (1-2) 217-222 NOV 6 1995
SCHENK DB, RYDEL RE, MAY P, et
al.
THERAPEUTIC
APPROACHES RELATED TO AMYLOID-BETA PEPTIDE AND ALZHEIMERS-DISEASE
J MED CHEM 38: (21) 4141-4154 OCT 13 1995
CASTANO EM, PRELLI FC, FRANGIONE
B
APOLIPOPROTEIN-E
AND AMYLOIDOGENESIS
LAB INVEST 73: (4) 457-460 OCT 1995
LEVINE H
SOLUBLE
MULTIMERIC ALZHEIMER BETA(1-40) PRE-AMYLOID COMPLEXES IN DILUTE-SOLUTION
NEUROBIOL AGING 16: (5) 755-764 SEP-OCT 1995
ZHAN SS, VEERHUIS R, KAMPHORST
W, et al.
DISTRIBUTION
OF BETA-AMYLOID ASSOCIATED PROTEINS IN PLAQUES IN ALZHEIMERS-DISEASE AND
IN THE NONDEMENTED ELDERLY
NEURODEGENERATION 4: (3) 291-297 SEP 1995
IVERSEN LL, MORTISHIRESMITH RJ,
POLLACK SJ, et al.
THE TOXICITY
IN-VITRO OF BETA-AMYLOID PROTEIN
BIOCHEM J 311: 1-16 Part 1 OCT 1 1995
YOSHIMOTO M, IWAI A, KANG D,
et al.
NACP,
THE PRECURSOR PROTEIN OF THE NONAMYLOID BETA/A4 PROTEIN (A-BETA) COMPONENT
OF ALZHEIMER-DISEASE AMYLOID, BINDS A-BETA AND STIMULATES A-BETA AGGREGATION
P NATL ACAD SCI USA 92: (20) 9141-9145 SEP 26 1995
SOTO C, CASTANO EM, PRELLI F,
et al.
APOLIPOPROTEIN-E
INCREASES THE FIBRILLOGENIC POTENTIAL OF SYNTHETIC PEPTIDES DERIVED FROM
ALZHEIMERS, GELSOLIN AND AA AMYLOIDS
FEBS LETT 371: (2) 110-114 SEP 4 1995
WISNIEWSKI T, GOLABEK AA, KIDA
E, et al.
CONFORMATIONAL
MIMICRY IN ALZHEIMERS-DISEASE - ROLE OF APOLIPOPROTEINS IN AMYLOIDOGENESIS
AM J PATHOL 147: (2) 238-244 AUG 1995
CASTANO EM, FRANGIONE B
NON-ALZHEIMERS
DISEASE AMYLOIDOSES OF THE NERVOUS-SYSTEM
CURR OPIN NEUROL 8: (4) 279-285 AUG 1995
21-30
ROSENBERG ME, SILKENSEN J
CLUSTERIN
- PHYSIOLOGICAL AND PATHOPHYSIOLOGIC CONSIDERATIONS
INT J BIOCHEM CELL B 27: (7) 633-645 JUL 1995
CASTANO EM, PRELLI F, PRAS M,
et al.
APOLIPOPROTEIN-E
CARBOXYL-TERMINAL FRAGMENTS ARE COMPLEXED TO AMYLOID-A AND AMYLOID-L -
IMPLICATIONS FOR AMYLOIDOGENESIS AND ALZHEIMERS-DISEASE
J BIOL CHEM 270: (29) 17610-17615 JUL 21 1995
KIDA E, CHOIMIURA NH, WISNIEWSKI
KE
DEPOSITION
OF APOLIPOPROTEIN-E AND APOLIPOPROTEIN-J IN SENILE PLAQUES IS TOPOGRAPHICALLY
DETERMINED IN BOTH ALZHEIMERS-DISEASE AND DOWNS-SYNDROME BRAIN
BRAIN RES 685: (1-2) 211-216 JUL 10 1995
STRITTMATTER WJ, ROSES AD
APOLIPOPROTEIN-E
AND ALZHEIMER-DISEASE
P NATL ACAD SCI USA 92: (11) 4725-4727 MAY 23 1995
GOLABEK A, MARQUES MA, LALOWSKI
M, et al.
AMYLOID-BETA
BINDING-PROTEINS IN-VITRO AND IN NORMAL HUMAN CEREBROSPINAL-FLUID
NEUROSCI LETT 191: (1-2) 79-82 MAY 19 1995
KOUNNAS MZ, LOUKINOVA EB, STEFANSSON
S, et al.
IDENTIFICATION
OF GLYCOPROTEIN-330 AS AN ENDOCYTIC RECEPTOR FOR APOLIPOPROTEIN-J/CLUSTERIN
J BIOL CHEM 270: (22) 13070-13075 JUN 2 1995
MORGAN TE, LAPING NJ, ROZOVSKY
I, et al.
CLUSTERIN
EXPRESSION BY ASTROCYTES IS INFLUENCED BY TRANSFORMING GROWTH-FACTOR-BETA-1
AND HETEROTYPIC CELL-INTERACTIONS
J NEUROIMMUNOL 58: (1) 101-110 APR 1995
MATSUBARA E, FRANGIONE B, GHISO
J
CHARACTERIZATION
OF APOLIPOPROTEIN J-ALZHEIMERS A-BETA INTERACTION
J BIOL CHEM 270: (13) 7563-7567 MAR 31 1995
FRACKOWIAK J, MAZURKOLECKA B,
WISNIEWSKI HM, et al.
SECRETION
AND ACCUMULATION OF ALZHEIMERS BETA-PROTEIN BY CULTURED VASCULAR SMOOTH-MUSCLE
CELLS FROM OLD AND YOUNG-DOGS
BRAIN RES 676: (1) 225-230 APR 3 1995
ROGERS J
INFLAMMATION
AS A PATHOGENIC MECHANISM IN ALZHEIMERS-DISEASE
ARZNEIMITTEL-FORSCH 45-1: (3A) 439-442 MAR 1995
11-20
LADU MJ, PEDERSON TM, FRAIL DE,
et al.
PURIFICATION
OF APOLIPOPROTEIN-E ATTENUATES ISOFORM-SPECIFIC BINDING TO BETA-AMYLOID
J BIOL CHEM 270: (16) 9039-9042 APR 21 1995
SISODIA SS, PRICE DL
ROLE
OF THE BETA-AMYLOID PROTEIN IN ALZHEIMERS-DISEASE
FASEB J 9: (5) 366-370 MAR 1995
GHISO J, PLANT GT, REVESZ T,
et al.
FAMILIAL
CEREBRAL AMYLOID ANGIOPATHY (BRITISH TYPE) WITH NONNEURITIC AMYLOID PLAQUE-FORMATION
MAY BE DUE TO A NOVEL AMYLOID PROTEIN
J NEUROL SCI 129: (1) 74-75 MAR 1995
YOUNKIN SG
THE AMYLOID-BETA
PROTEIN-PRECURSOR MUTATIONS LINKED TO FAMILIAL ALZHEIMERS-DISEASE ALTER
PROCESSING IN A WAY THAT POSTERS AMYLOID DEPOSITION
TOHOKU J EXP MED 174: (3) 217-223 NOV 1994
KOUDINOV A, MATSUBARA E, FRANGIONE
B, et al.
THE SOLUBLE
FORM OF ALZHEIMERS AMYLOID-BETA PROTEIN IS COMPLEXED TO HIGH-DENSITY-LIPOPROTEIN-3
AND VERY HIGH-DENSITY-LIPOPROTEIN IN NORMAL HUMAN PLASMA
BIOCHEM BIOPH RES CO 205: (2) 1164-1171 DEC 15 1994
ZLOKOVIC BV, MARTEL CL, MACKIC
JB, et al.
BRAIN
UPTAKE OF CIRCULATING APOLIPOPROTEIN-J AND APOLIPOPROTEIN-E COMPLEXED TO
ALZHEIMERS AMYLOID-BETA
BIOCHEM BIOPH RES CO 205: (2) 1431-1437 DEC 15 1994
FUKUYAMA R, WADHWANI KC, GALDZICKI
Z, et al.
BETA-AMYLOID
POLYPEPTIDE INCREASES CALCIUM-UPTAKE IN PC12 CELLS - A POSSIBLE MECHANISM
FOR ITS CELLULAR TOXICITY IN ALZHEIMERS-DISEASE
BRAIN RES 667: (2) 269-272 DEC 26 1994
-
NAKAMURA T, SHOJI M, HARIGAYA
Y, et al.
-
AMYLOID-BETA
PROTEIN-LEVELS IN CEREBROSPINAL-FLUID ARE ELEVATED IN EARLY-ONSET ALZHEIMERS-DISEASE
ANN NEUROL 36: (6) 903-911 DEC 1994
-
ODA T, PASINETTI GM, OSTERBURG
HH, et al.
-
PURIFICATION
AND CHARACTERIZATION OF BRAIN CLUSTERIN
BIOCHEM BIOPH RES CO 204: (3) 1131-1136 NOV 15 1994
-
LADU MJ, FALDUTO MT, MANELLI
AM, et al.
-
ISOFORM-SPECIFIC
BINDING OF APOLIPOPROTEIN-E TO BETA-AMYLOID
J BIOL CHEM 269: (38) 23403-23406 SEP 23 1994
1-10
-
GALLO G, WISNIEWSKI T, CHOIMIURA
NH, et al.
-
POTENTIAL
ROLE OF APOLIPOPROTEIN-E IN FIBRILLOGENESIS
AM J PATHOL 145: (3) 526-530 SEP 1994
-
SANAN DA, WEISGRABER KH, RUSSELL
SJ, et al.
-
APOLIPOPROTEIN-E
ASSOCIATES WITH BETA-AMYLOID PEPTIDE OF ALZHEIMERS-DISEASE TO FORM NOVEL
MONOFIBRILS - ISOFORM APOE4 ASSOCIATES MORE EFFICIENTLY THAN APOE3
J CLIN INVEST 94: (2) 860-869 AUG 1994
-
SCHWARZMAN AL, GREGORI L, VITEK
MP, et al.
-
TRANSTHYRETIN
SEQUESTERS AMYLOID-BETA PROTEIN AND PREVENTS AMYLOID FORMATION
P NATL ACAD SCI USA 91: (18) 8368-8372 AUG 30 1994
-
ZHAN SS, VEERHUIS R, JANSSEN
I, et al.
-
IMMUNOHISTOCHEMICAL
DISTRIBUTION OF THE INHIBITORS OF THE TERMINAL COMPLEMENT COMPLEX IN ALZHEIMERS-DISEASE
NEURODEGENERATION 3: (2) 111-117 JUN 1994
-
GHISO J, WISNIEWSKI T, FRANGIONE
B
-
UNIFYING
FEATURES OF SYSTEMIC AND CEREBRAL AMYLOIDOSIS
MOL NEUROBIOL 8: (1) 49-64 FEB 1994
-
WISNIEWSKI T, GHISO J, FRANGIONE
B
-
ALZHEIMERS-DISEASE
AND SOLUBLE A-BETA
NEUROBIOL AGING 15: (2) 143-152 MAR-APR 1994
-
SIMMONS LK, MAY PC, TOMASELLI
KJ, et al.
-
SECONDARY
STRUCTURE OF AMYLOID BETA-PEPTIDE CORRELATES WITH NEUROTOXIC ACTIVITY IN-VITRO
MOL PHARMACOL 45: (3) 373-379 MAR 1994
SISODIA SS, PRICE DL
AMYLOIDOGENESIS
IN ALZHEIMERS-DISEASE
CLIN NEUROSCI 1: (4) 176-183 1993
ZLOKOVIC BV, GHISO J, MACKIC
JB, et al.
BLOOD-BRAIN-BARRIER
TRANSPORT OF CIRCULATING ALZHEIMERS AMYLOID-BETA
BIOCHEM BIOPH RES CO 197: (3) 1034-1040 DEC 30 1993
WISNIEWSKI T, CASTANO E, GHISO
J, et al.
CEREBROSPINAL-FLUID
INHIBITS ALZHEIMER BETA-AMYLOID FIBRIL FORMATION IN-VITRO
ANN NEUROL 34: (4) 631-633 OCT 1993
Thanks for visiting Drs. Koudinov
Internet Office
Site Design and Programming © Alexei Koudinov, 2001.
Last updated: February, 2001